|
1 |
Creative Commons |
CMV serostatus is associated with improved survival and delayed toxicity onset following anti-PD-1 checkpoint blockade |
A conversation with Ben Fairfax about the recent article: CMV serostatus is associated with improved survival and delayed toxicity onset following anti-PD-1 checkpoint blockade. |
Ben Fairfax, Paul Klenerman |
13 Jun 2025 |
|
2 |
Creative Commons |
Optimising CAR-T cell sensitivity by engineering matched extracellular sizes between CAR/antigen and CD2/CD58 adhesion complexes |
Professor Omer Dusk discusses a bioRxiv pre-print: ‘Optimising CAR-T cell sensitivity by engineering matched extracellular sizes between CAR/antigen and CD2/CD58 adhesion complexes’. |
Omer Dushek, Paul Klenerman |
09 Jan 2025 |
|
3 |
|
Lights, Camera, Immuno-action! Research on cancer immunotherapy and its implications for the clinic |
Melissa Bedard explains the body’s lack of an immune response to cancer cells through an analogy with spy movies. |
Melissa Bedard |
03 Apr 2017 |
|
4 |
Creative Commons |
Cancer Immunlogy |
Professor Vincenzo Cerundolo tells us how research in immunology leads to the development of new cancer treatments. |
Vincenzo Cerundolo |
25 Mar 2013 |
|
5 |
Creative Commons |
Cancer Immunlogy |
Professor Vincenzo Cerundolo tells us how research in immunology leads to the development of new cancer treatments. |
Vincenzo Cerundolo |
25 Mar 2013 |
